[1]冯宏达.喜炎平联合利巴韦林治疗小儿手足口病的疗效[J].医学信息,2021,34(09):156-158.[doi:10.3969/j.issn.1006-1959.2021.09.042]
　FENG Hong-da.The Effect of Xiyanping Combined with Ribavirin in the Treatment of Hand, Foot and Mouth Disease in Children[J].Medical Information,2021,34(09):156-158.[doi:10.3969/j.issn.1006-1959.2021.09.042]
点击复制

喜炎平联合利巴韦林治疗小儿手足口病的疗效()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
34卷
期数:
2021年09期
页码:
156-158
栏目:
药物与临床
出版日期:
2021-05-01

文章信息/Info

Title:
The Effect of Xiyanping Combined with Ribavirin in the Treatment of Hand, Foot and Mouth Disease in Children
文章编号:
1006-1959（2021）09-0156-03
作者:
冯宏达
（佳木斯市中心医院儿内科，黑龙江 佳木斯 154007）
Author(s):
FENG Hong-da
(Department of Pediatrics,Jiamusi Central Hospital,Jiamusi 154007,Heilongjiang,China)
关键词:
喜炎平; 利巴韦林; 手足口病
Keywords:
Xiyanping; Ribavirin; Hand; foot and mouth
分类号:
R725.1
DOI:
10.3969/j.issn.1006-1959.2021.09.042
文献标志码:
A
摘要:
目的 观察喜炎平与利巴韦林治疗小儿手足口病的疗效。方法 选取2019年5月~2020年5月我院治疗的72例小儿手足口病患儿为研究对象，采用随机数字表法分为对照组和观察组，各36例。对照组采用利巴韦林治疗，观察组在对照组基础上加用喜炎平治疗，比较两组临床治疗效、体温恢复和临床症状消退时间、住院时间、炎症指标以及临床不良反应发生情况。结果 观察组治疗总有效率为94.44%，高于对照组的83.33%，差异有统计学意义（P＜0.05）；观察组体温恢复、皮疹消退、口腔疱疹消退以及住院时间均短于对照组，差异有统计学意义（P＜0.05）；观察组CRP、WBC、IL-6低于对照组，差异有统计学意义（P＜0.05）；观察组临床不良反应率为2.78%，低于对照组的13.89%，差异有统计学意义（P＜0.05）。结论 喜炎平与利巴韦林联合治疗小儿手足口病效果确切，可提高总有效率，快速改善患儿临床症状和体征，缩短住院时间，降低炎症指标水平，抑制炎症反应，且可降低临床不良反应，具有良好的治疗疗效和应用安全性。
Abstract:
Objective To observe the efficacy of Xiyanping and ribavirin in the treatment of hand, foot and mouth disease in children.Methods A total of 72 children with hand,foot and mouth disease treated in our hospital from May 2019 to May 2020 were selected as the research objects. They were divided into a control group and an observation group by random number table method, with 36 cases in each group.The control group was treated with ribavirin, and the observation group was treated with Xiyanping on the basis of the control group.The clinical treatment effect, body temperature recovery and clinical symptom resolution time, hospital stay, inflammation indicators and occurrence of clinical adverse reactions were compared between the two groups.Results The total effective rate of treatment in the observation group was 94.44%, which was higher than 83.33% in the control group,the difference was statistically significant (P<0.05);The body temperature recovery, rash subsidence, oral herpes subsidence and hospital stay in the observation group were shorter than those in the control group,the difference was statistically significant (P<0.05);CRP, WBC and IL-6 in the observation group were lower than those in the control group, the difference was statistically significant (P＜0.05);The clinical adverse reaction rate in the observation group was 2.78%, which was lower than 13.89% in the control group,the difference was statistically significant (P<0.05).Conclusion The combination of Xiyanping and ribavirin is effective in treating children with hand, foot and mouth disease.It can increase the total effective rate, quickly improve the clinical symptoms and signs of children, shorten the hospital stay, reduce the level of inflammatory indicators, inhibit inflammatory reactions, and can reduce clinical adverse reactions. It has good therapeutic efficacy and application safety.

参考文献/References:

[1]王良超.喜炎平联合利巴韦林治疗小儿手足口病的临床效果观察[J].中国实用医刊,2015,42(4):41-42. [2]唐晓芳,童晓玲,安阳阳.重组人干扰素α2b喷雾剂和利巴韦林喷雾剂治疗小儿手足口病的效果比较[J].川北医学院学报,2020,35(2):130-132. [3]中华中医药学会儿科分会临床评价学组.小儿手足口病中药新药临床试验设计与评价技术指南[J].药物评价研究,2015,38(5):465-471. [4]郭尚囡,廖友明,利汉其,等.小儿手足口病应用喜炎平和利巴韦林注射液的治疗效果研究[J].数理医药学杂志,2016,29(8):1202-1203. [5]顾红岩,刘志达,张玲,等.2015年北京地区手足口病 住院患儿的病原分布及临床特点[J].中华儿科杂志,2015,53(6):459-463. [6]姜波,余民浙,鲁春红,等.单磷酸阿糖腺苷联合口腔炎喷剂治疗手足口病疗效观察[J].中国基层医药,2014(16):2522-2524. [7]刘冰冰,华丽霞,董艳,等.喜炎平与利巴韦林治疗小儿手足口病疗效和安全性的系统评价[J].中国实验方剂学杂志,2014,20(9):231-236． [8]金萍,沈乐琴,陈勇南,等.喜炎平联合利巴韦林治疗小儿手足口病伴发热疗效观察[J].儿科药学杂志,2015,21(3):21-24. [9]Kimmis BD,Downing C,Tyring S.Hand-foot-and-mouth disease caused by coxsackievirus A6 on the rise[J].Cutis,2018,102(5):353-356. [10]Huang J,Liao Q,Ooi MH,et al.Epidemiology of Recurrent Hand, Foot and Mouth Disease, China, 2008-2015[J].Emerg Infect Dis,2018,24(3):432-442. [11]鲁利平,张睿.喜炎平与利巴韦林治疗小儿手足口病的疗效和安全性[J].中国医药指南,2015,13(21):222-223. [12]张建华,王莹,赵华,等.喜炎平联合利巴韦林治疗小儿手足口病的临床观察[J].中国现代药物应用,2015(10):101-102. [13]张玉山.喜炎平与单磷酸阿糖腺苷联合治疗小儿手足口病的临床效果观察[J].航空航天医学杂志,2015,26(2):216-218. [14]周惠卿.谭永红.热毒宁合利巴韦林治疗小儿手足口病87例临床观察[J].北方药学,2014,11(4):34-35． [15]李君霞,张志明,陈兰娇,等.炎琥宁联合干扰素治疗小儿手足口病的临床疗效观察[J].中国地方病防治杂志,2016,31(5):592. [16]周优树,王银玉,张林贵.蒲地蓝消炎口服液联合阿昔洛韦治疗小儿流行性腮腺炎38例[J].中国中医药现代远程教育,2014,12(2):54-55. [17]张会平,王丽,钱继红,等.利巴韦林气雾剂治疗小儿手足口病的有效性和安全性研究[J].中国当代儿科杂志,2014,16(3):272-275. [18]吴燕玲,李国伟,周杏,等.干扰素联合炎琥宁治疗小儿手足口病126例分析[J].黑龙江医药,2016,29(1):59-60.

相似文献/References:

[1]张小华,敏 峰,张玲丽.喜炎平联合单磷酸阿糖腺苷治疗小儿手足口病的 效果及安全性[J].医学信息,2019,32(15):157.[doi:10.3969/j.issn.1006-1959.2019.15.052]
　ZHANG Xiao-hua,MIN Feng,ZHANG Ling-li.Application Effect and Safety of Xiyanping Combined with Adenosine Monophosphate in the Treatment of Hand,Foot and Mouth Disease in Children[J].Medical Information,2019,32(09):157.[doi:10.3969/j.issn.1006-1959.2019.15.052]
[2]钟石古.喜炎平联合奥司他韦治疗流感病毒性肺炎的临床分析[J].医学信息,2025,38(04):107.[doi:10.3969/j.issn.1006-1959.2025.04.018]
　ZHONG Shigu.Clinical Analysis of Xiyanping Combined with Oseltamivir in the Treatment of Influenza Virus Pneumonia[J].Medical Information,2025,38(09):107.[doi:10.3969/j.issn.1006-1959.2025.04.018]

更新日期/Last Update: 1900-01-01